Ascendis Pharma A (ASND) Return on Capital Employed (QoQ) (2015 - 2026)

Ascendis Pharma A (ASND) Return on Capital Employed (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ascendis Pharma A 15.31 Bn 14.64 Bn 268.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,604.00
Dec 31, 2025 -29.77 Mn
Sep 30, 2025 -5.62 Mn
Jun 30, 2025 32.25 Mn
Mar 31, 2025 385,959.00
Dec 31, 2024 2.78 Mn
Sep 30, 2024 -94,563.00
Jun 30, 2024 380,717.00
Mar 31, 2024 -286,189.00
Dec 31, 2023 -30,116.00
Sep 30, 2023 -763.00
Jun 30, 2023 -983.00
Mar 31, 2023 -1,206.00
Dec 31, 2022 -1,054.00
Sep 30, 2022 -760.00
Jun 30, 2022 -1,042.00
Mar 31, 2022 130.00
Dec 31, 2021 1,737.00
Sep 30, 2021 141.00
Jun 30, 2021 -1,858.00